Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Circulation

• Publication date

  2016-02-02

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.115.018713PMID 26831434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.

  2015cited by this paper
• Impact of statins on serial coronary calcification during atheroma progression and regression.

  2015cited by this paper
• A randomized trial of intraarterial treatment for acute ischemic stroke.

  2015cited by this paper
• Cardiorenal syndrome: New perspectives

  2015cited by this paper
• Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials

  2015cited by this paper
• Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.

  2015cited by this paper
• Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

  2015cited by this paper
• Protein carbamylation is associated with heart failure and mortality in diabetic patients with end stage renal disease

  2015cited by this paper
• Cardiovascular and Renal Outcomes Trials-Is There a Difference?

  2015cited by this paper
• Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease

  2015cited by this paper
• The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease

  2015cited by this paper
• Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis

  2015cited by this paper
• Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View

  2015cited by this paper
• Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research.

  2015cited by this paper
• Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction

  2015cited by this paper
• Endovascular therapy for ischemic stroke with perfusion-imaging selection.

  2015cited by this paper
• Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation.

  2015cited by this paper
• Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View.

  2015cited by this paper
• The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients.

  2015cited by this paper
• Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction

  2015cited by this paper
• Randomized assessment of rapid endovascular treatment of ischemic stroke.

  2015cited by this paper
• Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Heart Failure

  2015cited by this paper
• Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators

  2015cited by this paper
• Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

  2015cited by this paper
• The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients

  2014cited by this paper
• Intersection of cardiovascular disease and kidney disease: atrial fibrillation

  2014cited by this paper
• Apixaban Use Among Patients With Severe Renal Impairment

  2014cited by this paper
• Prevalence of renal artery disease and its prognostic significance in patients undergoing coronary bypass grafting.

  2014cited by this paper
• Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

  2014cited by this paper
• Preoperative chronic kidney disease as a strong predictor of postoperative infection and mortality after coronary artery bypass grafting.

  2014cited by this paper
• Stroke and cerebrovascular diseases in patients with chronic kidney disease.

  2014influential reference
• Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.

  2014cited by this paper
• Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.

  2014cited by this paper
• Assessment and management of hypertension in patients on dialysis.

  2014influential reference
• Contrast-associated AKI and use of cardiovascular medications after acute coronary syndrome.

  2014cited by this paper
• Protein carbamylation in kidney disease: pathogenesis and clinical implications.

  2014cited by this paper
• Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup.

  2014cited by this paper
• The gut microbiome, kidney disease, and targeted interventions.

  2014cited by this paper
• Pathophysiology of the Cardiorenal Syndromes: Executive Summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)

  2014cited by this paper
• Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.

  2014cited by this paper
• Neprilysin inhibition in chronic kidney disease

  2014cited by this paper
• Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.

  2014cited by this paper
• FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.

  2014cited by this paper
• Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis

  2014cited by this paper
• Vitamin K Antagonists: Beyond Bleeding

  2014cited by this paper
• Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.

  2014cited by this paper
• Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

  2013cited by this paper
• The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial

  2013cited by this paper
• Adding Pharmacists to Primary Care Teams Increases Guideline-Concordant Antiplatelet Use in Patients with Type 2 Diabetes: Results from a Randomized Trial

  2013cited by this paper
• Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study

  2013cited by this paper
• Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

  2013cited by this paper
• Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: risks versus benefits review

  2013cited by this paper
• Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.

  2013cited by this paper
• Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome

  2013cited by this paper
• Stroke features and management in patients with chronic kidney disease.

  2013cited by this paper
• Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects.

  2013cited by this paper
• Revascularization of asymptomatic carotid stenosis is not appropriate in patients on dialysis.

  2013cited by this paper
• Protein carbamylation predicts mortality in ESRD.

  2013cited by this paper
• Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophages.

  2013cited by this paper
• Multidisciplinary care for poor patients with chronic kidney disease in Mexico

  2013cited by this paper
• Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis.

  2013cited by this paper
• Carbamylation of Serum Albumin as a Risk Factor for Mortality in Patients with Kidney Failure

  2013cited by this paper
• Association between LDL-C and risk of myocardial infarction in CKD.

  2013cited by this paper
• Proteinuria and clinical outcomes after ischemic stroke

  2012cited by this paper
• Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial.

  2012cited by this paper
• Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

  2012cited by this paper
• Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

  2012cited by this paper
• Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

  2012cited by this paper
• Using Proteinuria and Estimated Glomerular Filtration Rate to Classify Risk in Patients With Chronic Kidney Disease: A Cohort Study

  2012cited by this paper
• Risks of Death and End-Stage Renal Disease After Surgical Compared With Percutaneous Coronary Revascularization in Elderly Patients With Chronic Kidney Disease

  2012cited by this paper
• Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe

  2012cited by this paper
• A Systematic Review of the Evidence for Pharmacist Care of Patients With Dyslipidemia

  2012cited by this paper
• CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches.

  2012cited by this paper
• Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.

  2012cited by this paper
• Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

  2012cited by this paper
• Adding pharmacists to primary care teams reduces predicted long‐term risk of cardiovascular events in Type 2 diabetic patients without established cardiovascular disease: results from a randomized trial

  2012cited by this paper
• Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

  2012cited by this paper
• Notice

  2012cited by this paper
• Atrial fibrillation: the beat is faster than the answers.

  2012cited by this paper
• Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study.

  2012cited by this paper
• Vascular Calcification: Pathophysiology and Risk Factors

  2012cited by this paper
• The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

  2012cited by this paper
• Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease

  2012cited by this paper
• Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction.

  2012cited by this paper
• Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease

  2012cited by this paper
• Sudden Cardiac Death in Dialysis: Do Current Guidelines for Implantable Cardioverter Defibrillator Therapy Apply to Patients with End‐stage Kidney Disease?

  2012cited by this paper
• Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.

  2012cited by this paper
• Anticoagulants in atrial fibrillation patients with chronic kidney disease

  2012cited by this paper
• Association of catalytic iron with cardiovascular disease.

  2012cited by this paper
• FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

  2012cited by this paper
• Stroke and bleeding in atrial fibrillation with chronic kidney disease.

  2012cited by this paper
• Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.

  2012cited by this paper
• Epidemiology and genetics of sudden cardiac death.

  2012cited by this paper
• Survival trends of US dialysis patients with heart failure: 1995 to 2005.

  2011cited by this paper
• Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy

  2011cited by this paper
• The increasing prevalence of atrial fibrillation among hemodialysis patients.

  2011cited by this paper
• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  2011cited by this paper
• Association between stroke center hospitalization for acute ischemic stroke and mortality.

  2011cited by this paper
• Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes.

  2011cited by this paper
• FGF23 induces left ventricular hypertrophy.

  2011cited by this paper

• Prevalence of Cardiovascular Disease in Patients with Chronic Kidney Disease: A Hospital Based Study in Bangladesh

  2026cites this paper
• Targeting pathological chemokines in CVD: the role of saffron on CCL2 and CXCL8

  2026cites this paper
• The creatinine-to-body weight ratio predicts mortality in critically ill patients with heart failure: a retrospective cohort study of the MIMIC-IV database

  2026cites this paper
• Comparison of different lipid abnormalities between hemodialysis and peritoneal dialysis in patients with ESRD

  2025cites this paper
• Ischemic and non-ischemic myocardial injuries at autopsy- an overview for forensic pathologists

  2025cites this paper
• LARP7 Protects Vascular Smooth Muscle Cell Contractile Phenotype in CKD by Coupling with P300.

  2025cites this paper
• A risk prediction model for neovascular glaucoma secondary to proliferative diabetic retinopathy based on Boruta feature selection and random forest

  2025cites this paper
• Protein risk scores enable precise prediction of cardiovascular events in chronic kidney disease patients

  2025cites this paper
• Microbiota and kidney disease: the road ahead

  2025cites this paper
• Association of electrocardiographic abnormalities with major adverse cardiovascular events in kidney transplant recipients.

  2025cites this paper
• Trends in Cardiovascular Mortality in Patients With Chronic Kidney Disease From 1999 to 2020: A Retrospective Study in the United States

  2025cites this paper
• Bioinformatics gene analysis of potential biomarkers associated with chronic kidney disease related ischemic stroke

  2025cites this paper
• Percutaneous Coronary Intervention for Acute Coronary Syndrome in Young Adults on Dialysis: Insights from Houston Methodist Young ACS-PCI Registry.

  2025cites this paper
• Astragaloside IV attenuates uremia-induced myocardial injury by inhibiting autophagy via ATF4

  2025cites this paper
• Advanced Echocardiographic Approaches for Assessing Cardiac Dysfunction in Chronic Kidney Disease: Current Techniques and Future Perspectives

  2025cites this paper
• Nanocellulose/activated carbon composite aerogel beads with high adsorption capacity for toxins in blood.

  2025cites this paper
• Nanocellulose/Graphene Oxide Composite Beads as a Novel Hemoperfusion Adsorbent for Efficient Removal of Bilirubin Plasma.

  2025cites this paper
• Single versus bilateral internal thoracic artery grafting in patients with impaired renal function

  2024cites this paper
• Update on HD-Induced Multiorgan Ischemia: Brains and Beyond.

  2024cites this paper
• Comprehensive characterization of protein modifications using mass spectrometry and dry blood spots

  2024cites this paper
• Association between systemic immune inflammation Index and all-cause mortality in incident peritoneal dialysis-treated CKD patients: a multi-center retrospective cohort study

  2024cites this paper
• Gut matters in microgravity: potential link of gut microbiota and its metabolites to cardiovascular and musculoskeletal well-being

  2024cites this paper
• ASSOCIATION BETWEEN CARDIO-ANKLE VASCULAR INDEX, VENTRICULAR-ARTERIAL COUPLING AND HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION AMONG THAI CHRONIC KIDNEY DISEASE PATIENTS

  2024cites this paper
• Cardiac Urea Cycle Activation by Time‐Restricted Feeding Protects Against Pressure Overload‐Induced Heart Failure

  2024cites this paper
• Atherosclerotic Diseases in Chronic Kidney Disease

  2024cites this paper
• Adropin a candidate diagnostic biomarker for cardiovascular disease in patients with chronic kidney disease

  2024cites this paper
• The joint effects of inflammation and renal function status on in-hospital outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis

  2024cites this paper
• Association between lipoprotein (a) and risk of atherosclerotic cardiovascular disease events among maintenance hemodialysis patients in Beijing, China: a single-center, retrospective study

  2024cites this paper
• The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis.

  2024cites this paper
• Accelerated idioventricular rhythm as a manifestation of chronic renocardiac syndrome: A case report

  2024cites this paper
• Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance

  2024cites this paper
• New-onset atrial fibrillation following arteriovenous fistula increases adverse clinical events in dialysis patients with end-stage renal disease

  2024cites this paper
• Data independent acquisition reveals in-depth serum proteome changes in uremic pruritus

  2024cites this paper
• Indoxyl sulphate‐initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor‐erythroid‐2‐related factor 2

  2024cites this paper
• Acute and Chronic Kidney Dysfunction and Prognosis following Thrombectomy for Ischemic Stroke

  2024cites this paper
• Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001–2018)

  2024influential citation
• Unravelling the Complexities of Myocardial Injury in Patients with Chronic Kidney Disease

  2024cites this paper
• Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients

  2023cites this paper
• Adiponectin C1q/Tumor Necrosis Factor-Related Protein 13 (CTRP13) Protects against Renal Inflammation and Fibrosis in Obstructive Nephropathy

  2023cites this paper
• Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease

  2023cites this paper
• Mapping cardiac remodeling in chronic kidney disease

  2023cites this paper
• Evaluating the effect of Roxadustat on ventricular repolarization in patients undergoing peritoneal dialysis

  2023cites this paper
• Mean platelet volume may predict all-cause and cardiovascular mortality among incident peritoneal dialysis patients

  2023cites this paper
• Non-Ischemic Myocardial Fibrosis in End-Stage Kidney Disease Patients: A New Perspective

  2023cites this paper
• Assessment of the Prognostic Value of MRI Left Ventricular Global Function Index (LVGFI) in Patients With End‐Stage Renal Disease Under Maintenance Dialysis

  2023cites this paper
• Correlation between renal metabolism and cardiovascular disease

  2023cites this paper
• Ambulatory Blood Pressure Monitoring as a Useful Tool in the Cardiological Assessment of Pancreas Transplant Recipients with Type 1 Diabetes

  2023cites this paper
• Artificially induced in situ macrophage polarization: An emerging cellular therapy for immuno-inflammatory diseases.

  2023cites this paper
• Exercise Rehabilitation for People with End-Stage Kidney Disease: Who will Fill the Gaps?

  2023cites this paper
• The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review

  2023influential citation
• Combined evaluation of Geriatric nutritional risk index and Neutrophil to lymphocyte ratio for predicting all-cause and cardiovascular mortality in hemodialysis patients

  2023cites this paper
• Left Ventricular Vertical Run‐Length Nonuniformity MRI Adds Prognostic Value to MACE in Patients with End‐Stage Renal Disease

  2023cites this paper
• Cardiac Imaging Biomarkers in Chronic Kidney Disease

  2023cites this paper
• Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients

  2023cites this paper
• Get to the heart of pediatric kidney transplant recipients: Evaluation of left- and right ventricular mechanics by three-dimensional echocardiography

  2023cites this paper
• Natural flavonoids derived from herbal medicines are potential anti-atherogenic agents by inhibiting oxidative stress in endothelial cells

  2023cites this paper
• Kidney disease and stroke: epidemiology and potential mechanisms of susceptibility.

  2023cites this paper
• Indoxyl sulfate in uremia: an old idea with updated concepts

  2022cites this paper
• Prevalence and Clinical Impact of Electrocardiographic Abnormalities in Patients with Chronic Kidney Disease

  2022cites this paper
• Intravital microscopic observation of the microvasculature during hemodialysis in healthy rats

  2022cites this paper
• Erythropoietin's Influence on Renal Anemia Treatment: Review Article

  2022cites this paper
• The Association Between Visceral Adiposity Index and Worsening Renal Function in the Elderly

  2022cites this paper
• High serum β2‐microglobulin is a significant predictor of mortality in maintenance hemodialysis patients

  2022cites this paper
• Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease

  2022cites this paper
• Chronic Kidney Disease Is Associated With Increased Cardiac Corin Expression But Decreased Proatrial Natriuretic Peptide Conversion Activity

  2022cites this paper
• SIRPα Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease

  2022cites this paper
• High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study.

  2022cites this paper
• T1 and T2 Mapping in Uremic Cardiomyopathy: An Update

  2022cites this paper
• Ameliorating effect of gum arabic on the liver tissues of the uremic rats; A biochemical and histological study.

  2022cites this paper
• The Relationship of Epicardial Adipose Tissue and Cardiovascular Disease in Chronic Kidney Disease and Hemodialysis Patients

  2022cites this paper
• Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients

  2021cites this paper
• Involvement of chronic inflammation via monocyte chemoattractant protein‐1 in uraemic cardiomyopathy: a human biopsy study

  2021cites this paper
• Impact of renal function on residual platelet reactivity and clinical outcomes in patients with acute coronary syndrome treated with clopidogrel

  2021cites this paper
• Fish oil replacement prevents, while docosahexaenoic acid‐derived protectin DX mitigates end‐stage‐renal‐disease in atherosclerotic diabetic mice

  2021cites this paper
• End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study

  2021cites this paper
• Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation

  2021cites this paper
• Metabolomics Evaluation of Patients With Stage 5 Chronic Kidney Disease Before Dialysis, Maintenance Hemodialysis, and Peritoneal Dialysis

  2021cites this paper
• Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial

  2021cites this paper
• Metabolic Acidosis and Cardiovascular Disease in CKD

  2021cites this paper
• Layer-speci c speckle tracking analysis of left ventricular systolic function and synchrony in maintenance hemodialysis patients

  2021cites this paper
• High-density lipoprotein cholesterol to apolipoprotein A1 ratio and all-cause mortality among incident peritoneal dialysis patients.

  2021cites this paper
• The Effect of Sacubitril/Valsartan in a Dialysis Patient with Severe Heart Failure

  2021cites this paper
• 1‐Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway

  2021cites this paper
• Study of the relationship between neutrophil-to-lymphocyte ratio and parathyroid hormone levels in patients undergoing hemodialysis, Isfahan, Iran

  2021cites this paper
• Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study

  2021cites this paper
• Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality

  2021cites this paper
• Prescription Practices in Patients With Mild to Moderate CKD in India

  2021cites this paper
• Cardiovascular Disease Epidemiology and Risk Factors: General Concepts

  2021cites this paper
• A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease

  2021cites this paper
• Right Ventricular Functionality Following Hemodialysis Initiation in End-Stage Kidney Disease—A Single-Center, Prospective, Cohort Study

  2021cites this paper
• Silent neurological lesions detected by magnetic resonance imaging: Relationship to hyperparathyroidism among end‐stage renal disease young patients on haemodialysis

  2021cites this paper
• The renal replacement therapy landscape in 2030: reducing the global cardiovascular burden in dialysis patients

  2020cites this paper
• Dissociation between hypertrophy and fibrosis in the left ventricle early after experimental kidney transplantation.

  2020influential citation
• Construction of Kevlar nanofiber/graphene oxide composite beads as safe, self-anticoagulant, and highly efficient hemoperfusion adsorbents.

  2020cites this paper
• Increased history of ischemic stroke and decreased neurocognitive performance in children with chronic kidney disease

  2020cites this paper
• Monocyte/Lymphocyte Ratio and Cardiovascular Disease Mortality in Peritoneal Dialysis Patients

  2020cites this paper
• Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases.

  2020cites this paper
• Duration of predialysis nephrological care and mortality after dialysis initiation

  2020cites this paper
• Serum Klotho, Cardiovascular Events, and Mortality in Nondiabetic Chronic Kidney Disease

  2020cites this paper
• Monocyte to high-density lipoprotein ratio and cardiovascular events in patients on peritoneal dialysis.

  2020cites this paper